Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP

million, or 6.65%, in the first quarter of 2021 due to the Company’s more contract manufacturing in full-service format, resulting in the recognition of cost of raw materials and packaging materials

Baht 1.98 million, because the Company had to reserve packages and raw materials for customers in manufacturing. - Investment in the associated companies decreased by Baht 3.78 million, due to the

. - Inventories increased by Baht 20.23 million, because the Company had to reserve packages and raw materials for customers and new customers in manufacturing. - Lease receivables were decreased by Baht 2.27

period. due to the Company’s more contract manufacturing in full-service format, resulting in the recognition of cost of raw materials and packaging materials included in the cost of sales and services

fruit juices. - Inventories increased by Baht 19.10 million, because the Company had to reserve packages and raw materials for customers and new customers in manufacturing. - Investment in the associated

raw materials for customers in manufacturing. - Investment in the associated companies decreased by Baht 126.91 million, due to the recognized share of profit in the associate companies. - Land

revenue in the contract manufacturing business of milk, drinks, and fruit juices. - Inventories increased by Baht 8.99 million, because the Company had to reserve packages and raw materials for customers

increased revenue in the contract manufacturing business of milk, drinks, and fruit juices. - Inventories increased by Baht 15.05 million, because the Company had to reserve packages and raw materials for

. - Inventories increased by Baht 26.28 million, because the Company had to reserve packages and raw materials for customers and new customers in manufacturing. - Lease receivables were decreased by Baht 7.86